KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Interest & Investment Income (2016 - 2025)

Evolent Health (EVH) has 10 years of Interest & Investment Income data on record, last reported at $868000.0 in Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 4.58% year-over-year to $868000.0; the TTM value through Dec 2025 reached $4.2 million, down 24.42%, while the annual FY2025 figure was $4.2 million, 24.42% down from the prior year.
  • Interest & Investment Income reached $868000.0 in Q4 2025 per EVH's latest filing, down from $964000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.6 million in Q1 2024 and bottomed at $68000.0 in Q2 2021.
  • Average Interest & Investment Income over 5 years is $838300.0, with a median of $812000.0 recorded in 2024.
  • The widest YoY moves for Interest & Investment Income: up 9700.0% in 2021, down 90.35% in 2021.
  • A 5-year view of Interest & Investment Income shows it stood at $96000.0 in 2021, then surged by 529.17% to $604000.0 in 2022, then skyrocketed by 317.38% to $2.5 million in 2023, then tumbled by 67.08% to $830000.0 in 2024, then rose by 4.58% to $868000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $868000.0 in Q4 2025, $964000.0 in Q3 2025, and $1.1 million in Q2 2025.